|
Shandong Binzhou Zhiyuan Biotechnology Co., Ltd
|
CAS: 182410-00-0
Abbreviation: SBEBCD
Molecular weight: 1135+158n
Standard : USP /EP
Package: 500g/bag , 1kg/bag , 2kg/bag, 10kg/drum
Use: medical
Packaging & Delivery
Packaging Details
Inner Packaging:500g/Bag,1kg/Bag,2kg/Bag,10kg/Bag,20kg/Bag
Outer Packaging:10kg/Drum,20kg/Drum.
Loading Port: Qingdao,Beijing,Shanghai,Tianjin,Dalian Etc. As Your Requirement.
Sulfobutyl ether beta cyclodextrin sodium is a high water-soluble anionic cyclodextrin derivative. It can easily form non-covalent inclusion complexes with drug molecules, thus it has the good performances in enhancing drug stability, solubility and safety, reducing drug toxicity and hemolysis, covering up bad smell, and controlling drug release rate.
|
Send Inquiry
|
|
Shandong Binzhou Zhiyuan Biotechnology Co., Ltd
|
Function of sulfobutylether beta-cyclodextin:
1.Sodium Sulfobutylether-β-Cyclodextrin is an important modified production of Beta-Cyclodextrin.
2. Sodium Sulfobutylether-Beta-Cyclodextrin is a newly researched and developed production of our company.
3.It has its own characteristics in addition to the ones Beta-Cyclodextrin has.
4.It is mainly used in the azotic medicine as an excipient.
Binzhou Zhiyuan supply below Services
1. Professional manufacturer with advanced facility.
2. We are leading manufacturer of sulfobutylether beta cyclodextrin,injection grade
3. Factory price with best quality.
4. Fast service and on-time delivery
5. Small quantity samples are available at any time.
|
Send Inquiry
|
|
Shandong Binzhou Zhiyuan Biotechnology Co., Ltd
|
Sulfamyclobutyl cyclodextrin is an excipient, mainly used in nitrogenous drugs.
It has special affinity and encapsulation for nitrogenous drugs
strong point:
1. Solubilization:
Neutral, positive, and negative drug substances can be effectively combined with sulfobutyl beta-cyclodextrin to increase the solubility of compounds in the drug solution by 10 to 25,000 times.
2, convenient for administration:
Sulfobutyl betacyclodextrin sodium has good biocompatibility and can be administered by injection, oral, ocular, nasal, topical and inhalation.
3. Good security:
It is usually eliminated from the kidneys quickly and completely after administration. In vitro and in vivo acute, subacute and chronic toxicity studies provide safe data and are approved for use in human pharmaceutical preparations.
4. Good stability:
The interaction with sodium sulfobutyl beta-cyclodextrin provides a beneficial protective environment for the drug substance in its lipophilic cavity, while the hydrophilic surface provides excellent water solubility to provide solubility and stability.
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
